๐๏ธ Verified NIH Record โข Updated 2026-04-14
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head (NCT05706909)
๐ต Active, Not Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: The Cleveland Clinic
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to assess the clinical and x-ray results of patients who are treated with core decompression of the hip and the injection of a bone marrow concentrate and the use of the Bone Graft Substitute Genexยฎ.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (4 items).
Location: Cleveland Clinic โ Cleveland, Ohio
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Subject is pregnant at the time of surgery
- Subject is incarcerated
- Subject is not comfortable with speaking, reading and understanding questions and providing responses in an available language for the questionnaires provided for the study
๐ Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
๐ All Participating Trial Locations (1 Sites)
- Cleveland Clinic โ Cleveland, Ohio
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.